Sequential Therapy with Docetaxel and Cabazitaxel Starting at Low PSA Levels was Associated with Longer Survival in Patients with Castration-Resistant Prostate Cancer

Naoki Terada, Toshiyuki Kamoto, Hiroaki Kawanisi et al.|Research Square|2021

Cited by 0